Literature DB >> 12835944

Etiopathogenesis of cholesteatoma.

Ewa Olszewska1, Mathias Wagner, Manuel Bernal-Sprekelsen, Jörg Ebmeyer, Stefan Dazert, Henning Hildmann, Holger Sudhoff.   

Abstract

Cholesteatoma is a destructive lesion of the temporal bone that gradually expands and causes complications by erosion of the adjacent bony structures. Bone resorption can result in destruction of the ossicular chain and otic capsule with consecutive hearing loss, vestibular dysfunction, facial paralysis and intracranial complications. Surgery is the only treatment of choice. The etiopathogenesis of cholesteatoma, however, is still controversial. This review was designed to understand the reasons for these disparities and to reduce or eliminate them. Future studies focused on developmental, epidemiological, hormonal and genetic factors as well as on treatment are likely to contribute to further understanding of cholesteatoma pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835944     DOI: 10.1007/s00405-003-0623-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  125 in total

1.  The motility of keratinocytes in cholesteatoma: an ultrastructural approach to epithelial migration.

Authors:  A C Robinson; M Hawke
Journal:  J Otolaryngol       Date:  1991-10

2.  Pathogenesis and surgical treatment of the middle ear cholesteatoma.

Authors:  L Rüedi
Journal:  Acta Otolaryngol Suppl       Date:  1979

3.  Functional thrombomodulin expression on epithelial skin tumours as a differentiation marker for suprabasal keratinocytes.

Authors:  H Mizutani; S Ohyanagi; T Hayashi; R W Groves; K Suzuki; M Shimizu
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

Review 4.  Bricks and mortar of the epidermal barrier.

Authors:  Z Nemes; P M Steinert
Journal:  Exp Mol Med       Date:  1999-03-31       Impact factor: 8.718

5.  Epidemiology and aetiology of middle ear cholesteatoma.

Authors:  H O Kemppainen; H J Puhakka; P J Laippala; M M Sipilä; M P Manninen; P H Karma
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

6.  Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear.

Authors:  S Ergün; B Carlsöö; X Zheng
Journal:  Clin Otolaryngol Allied Sci       Date:  1999-08

7.  Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.

Authors:  J Bujía; V Schilling; A Holly; M Stammberger; E Kastenbauer
Journal:  Acta Otolaryngol       Date:  1993-05       Impact factor: 1.494

8.  The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes.

Authors:  K Paukkonen; A Naukkarinen; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

9.  The natural history of congenital cholesteatoma.

Authors:  Peter J Koltai; Marc Nelson; Roberto J Castellon; Erea-Noel Garabedian; Jean-Michel Triglia; Stephane Roman; Gilles Roger
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

10.  Mammalian collagenase predisposes bone surfaces to osteoclastic resorption.

Authors:  T J Chambers; J A Darby; K Fuller
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

View more
  73 in total

1.  Middle ear cholesteatoma in 11 dogs.

Authors:  Valentina Greci; Olga Travetti; Mauro Di Giancamillo; Rocco Lombardo; Chiara Giudice; Barbara Banco; Carlo M Mortellaro
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

2.  Galectin-1, -3, -7 expressions in congenital and acquired pediatric cholesteatomas compared to external auditory canal skin.

Authors:  Marc Vander Ghinst; Myriam Remmelink; Anne-Laure Mansbach; Sergio Hassid; Georges Choufani
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-06-12       Impact factor: 3.372

3.  Apoptosis in the pathogenesis of cholesteatoma in adults.

Authors:  Ewa Olszewska; Stanislaw Chodynicki; Lech Chyczewski
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-24       Impact factor: 2.503

4.  Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide; Hiroshi Shimoda; Seiji Kato
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

5.  Prevalence of Cholesteatoma in Children With Down Syndrome Receiving Treatment at Pediatric Health Care Facilities.

Authors:  Alycia Spinner; Ajit Munjuluru; Christopher T Wootten
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-09-01       Impact factor: 6.223

Review 6.  Cholesteatoma Pearls: Practical Points and Update.

Authors:  James T Castle
Journal:  Head Neck Pathol       Date:  2018-08-01

7.  Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.

Authors:  Tolgahan Çatlı; Yıldırım Bayazıt; Akın Yılmaz; Adnan Menevşe; Ozan Gökdoğan; Nebil Göksu; Suat Özbilen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-06       Impact factor: 2.503

8.  Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.

Authors:  Mirosław Szczepański; Witold Szyfter; Renata Jenek; Maciej Wróbel; Iwona Mozer Lisewska; Jan Zeromski
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-15       Impact factor: 2.503

9.  Imaging findings in auto-atticotomy.

Authors:  M Manasawala; M E Cunnane; H D Curtin; G Moonis
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-14       Impact factor: 3.825

10.  Aggressiveness of pediatric cholesteatoma. Do we have an evidence?

Authors:  Zareen A Lynrah; Jaimanti Bakshi; Naresh K Panda; N K Khandelwal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.